VYNE Therapeutics Inc.
VYNE | NASDAQ
$28.56
$0.00 (0.00%)
Nov 2, 2026, 12:55 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -3.01M | -3.59M | -4.84M | -7.28M | -5.76M | -8.61M | -12.02M | -12.16M | -9.41M | -6.25M | -6.19M | -6.07M | -10.04M | -5.61M | -9.95M | -9.26M | -8.48M | 4.67M | -11.57M | -14.28M | -10.69M | -20.55M |
Depreciation & Amortization | 3K | -12K | 5K | 6K | 6K | 6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -155K | 171K | 12K | 44K | 26K | 28K | 28K | 27K |
Stock-Based Compensation | 436K | 474K | 529K | 487K | 529K | 763K | 699K | 734K | 885K | 985K | 710K | 863K | 876K | 856K | 1.07M | 1.17M | 1.16M | 893K | 1.33M | 2.41M | 1.9M | 2.44M |
Other Working Capital | n/a | n/a | n/a | -25K | -37K | -37K | -23K | -22K | -35K | -34K | 113K | 508K | -263K | -780K | 2.52M | -31K | -1.2M | -9.73M | -1.75M | 335K | -247K | 404K |
Other Non-Cash Items | -382K | -18K | -90K | -150K | -214K | -324K | -541K | -505K | -616K | -778K | -254K | 350K | 856K | 846K | 280K | 1.01M | 40K | -13M | 1.3M | -1.74M | -7.42M | -174K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 93K | n/a | n/a | n/a |
Change in Working Capital | 958K | -958K | 629K | -159K | -5.37M | -3.3M | 2.87M | 3.42M | 655K | -1.94M | 595K | 569K | -392K | -712K | 4.88M | 950K | -964K | -1.65M | -1.2M | -1.55M | 1.82M | 5.7M |
Operating Cash Flow | -1.99M | -4.08M | -3.76M | -7.1M | -10.8M | -11.46M | -9M | -8.51M | -8.48M | -7.98M | -5.14M | -5.15M | -9.57M | -5.48M | -3.88M | -7.13M | -8.23M | -9.04M | -10.02M | -17.54M | -16.26M | -12.55M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -117K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | -935K | -86K | n/a | 15.75M | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -790K | -6.8M | -9.58M | -13.77M | -10.05M | -28.42M | -6.88M | -15.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 300K | 4.7M | 9.25M | 11.2M | 14.25M | 33.6M | 22.9M | 23.6M | 25.9M | 11.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.03M | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -62.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 300K | 4.7M | 8.46M | 4.4M | 4.68M | 19.83M | 12.74M | -4.82M | 19.02M | -3.57M | -62.35M | n/a | n/a | 5M | -935K | -86K | n/a | 15.75M | n/a | n/a | 1.03M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36.43M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -15K | -7K | -34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -360K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -14K | n/a | n/a | n/a | n/a | n/a | -132K | -2K | -2K | -5K | -2K | n/a | n/a | n/a | 209K | n/a | 25K | -25K | -9K | n/a | n/a | 376K |
Financial Cash Flow | -14K | -15K | -15K | -7K | -34K | -87K | -132K | -2K | -2K | -5K | 82.66M | -47K | -5K | -217K | 208K | -26K | -61K | 1.53M | -38K | -33.56M | -129K | 73.5M |
Net Cash Flow | -1.71M | 604K | 4.68M | -2.7M | -6.16M | 8.28M | 3.61M | -13.34M | 10.54M | -11.56M | 15.17M | -5.2M | -9.58M | -695K | -4.6M | -7.24M | -8.29M | 8.25M | -10.06M | -51.1M | -15.36M | 60.95M |
Free Cash Flow | -1.99M | -4.08M | -3.76M | -7.1M | -10.8M | -11.46M | -9.12M | -8.51M | -8.48M | -7.98M | -5.14M | -5.15M | -9.57M | -5.48M | -3.88M | -7.13M | -8.23M | -9.04M | -10.02M | -17.54M | -16.26M | -12.55M |
Adj. Free Cash Flow | -2.43M | -4.56M | -4.29M | -7.58M | -11.33M | -12.22M | -9.82M | -9.24M | -9.37M | -8.97M | -5.85M | -6.02M | -10.45M | -6.33M | -4.94M | -8.3M | -9.39M | -9.93M | -11.35M | -19.95M | -18.16M | -14.99M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -116.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -888 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -1.99M | -4.08M | -3.76M | -7.1M | -10.8M | -11.46M | -9.12M | -8.51M | -8.48M | -7.98M | -5.14M | -5.15M | -9.57M | -5.48M | -3.88M | -7.13M | -8.23M | -9.04M | -10.02M | -17.54M | -16.26M | -12.55M |
Add to Watchlist
Select watchlists to add or remove VYNE